Cellectar Biosciences Inc (NASDAQ:CLRB) currently has a daily average trading volume of 11.87M but it saw 5530107 shares traded in last market. With a market cap of 20.14M USD, the company’s current market price of $0.44 came rising about 2.39 while comparing to the previous closing price of $0.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.42 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.41 while lowest mark touched by it was $0.465.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Ladenburg Thalmann which resumed the stock as “Buy” in its note to investors issued on December 05, 2024, recommending a price target of $13 for it. ROTH Capital also issued its recommendations for the stock as it resumed the price target for the stock is $10.
Over the week, CLRB’s stock price is moving 7.08% up while it is 82.08% when we observe its performance for the past one month. Year-to-date it is 46.15% up and over the past year, the stock is showing a downside performance of -86.68%.
Currently, Cellectar Biosciences Inc’s total number of outstanding shares is 46.08M with 1.71% of that held by the insiders while 12.42% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -244.91% and return on equity (ROE) at -208.72%. Stock’s beta reads 0.56. Stock has a price to book (P/B) ratio of 2.60. Its return on asset (ROA) is -83.27% on average.
